Original enteric-release technology:
Muti-target of antibacterial mechanisms:
1.Destruction of bacterial cell membrane.
2.Enter the cell and increase the pH pressure inside and outside the bacteria.
3.Bacterial lipase inhibitor.
4.Uncoupling of the electronic chain of bacterial respiration action and inhibit ATP synthesis.
Characteristics
1.Broad-spectrum antibacterial activity,especially to Clostridium perfringens (Table 1).
2.The strongest antimicrobial Middle chain fatty acid.
3.An original enteric-release preparation to maintain effective concentration for pathogens inhibition.
4.Highly effective against animal diarrhea, watery stools, blood dysentery, ileitis, necrotizing enteritis, etc.
5.Generally Recognized as Safe.
Customer benefits
1.Alternative to all AGPs with equivalent mechanism, efficiency and cost.
2.NO drug resistance, NO residue, NO withdrawal time.
3.Widely application for all animals on gut healthy and growth promotion.
Trials:
Dosage:
